SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引：0

作者：

Alonso-Gordoa, Teresa ^{[1
]}

Jimenez-Fonseca, Paula ^{[2
]}

Martinez-Trufero, Javier ^{[3
]}

Navarro, Miguel ^{[4
]}

Porras, Ignacio ^{[5
]}

Rubio-Casadevall, Jordi ^{[6
]}

Arregui Valles, Marta ^{[7
]}

Baste, Neus ^{[8
]}

Hernando, Jorge ^{[9
]}

Iglesias Docampo, Lara ^{[10
]}

机构：

[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain

[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain

[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain

[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain

[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain

[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain

[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain

[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain

[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain

[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;

D O I：

10.1007/s12094-024-03736-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.

引用

页码：2902 / 2916

页数：15

共 50 条

[21] SEOM clinical guideline on hereditary colorectal cancer (2019)
C. Guillén-Ponce
E. Lastra
I. Lorenzo-Lorenzo
T. Martín Gómez
R. Morales Chamorro
A. B. Sánchez-Heras
R. Serrano
M. C. Soriano Rodríguez
J. L. Soto
L. Robles
Clinical and Translational Oncology, 2020, 22 : 201 - 212
[22] SEOM clinical guideline for treatment of kidney cancer (2019)
Lazaro, M.
Valderrama, B. P.
Suarez, C.
de-Velasco, G.
Beato, C.
Chirivella, I.
Gonzalez-del-Alba, A.
Lainez, N.
Mendez-Vidal, M. J.
Arranz, J. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 256 - 269
[23] SEOM clinical guideline on unknown primary cancer (2017)
F. Losa
G. Soler
A. Casado
A. Estival
I. Fernández
S. Giménez
F. Longo
R. Pazo-Cid
J. Salgado
M. Á. Seguí
Clinical and Translational Oncology, 2018, 20 : 89 - 96
[24] SEOM Clinical Guideline of localized rectal cancer (2016)
E. González-Flores
F. Losa
C. Pericay
E. Polo
S. Roselló
M. J. Safont
R. Vera
J. Aparicio
M. T. Cano
C. Fernández-Martos
Clinical and Translational Oncology, 2016, 18 : 1163 - 1171
[25] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
Vera, R.
Dotor, E.
Feliu, J.
Gonzalez, E.
Laquente, B.
Macarulla, T.
Martinez, E.
Maurel, J.
Salgado, M.
Manzano, J. L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1172 - 1178
[26] SEOM clinical guideline for treatment of kidney cancer (2017)
E. Gallardo
M. J. Méndez-Vidal
J. L. Pérez-Gracia
J. M. Sepúlveda-Sánchez
M. Campayo
I. Chirivella-González
X. García-del-Muro
A. González-del-Alba
E. Grande
C. Suárez
Clinical and Translational Oncology, 2018, 20 : 47 - 56
[27] SEOM clinical guideline for treatment of cancer pain (2017)
C. Jara
S. del Barco
C. Grávalos
S. Hoyos
B. Hernández
M. Muñoz
T. Quintanar
J. A. Meana
C. Rodriguez
R. de las Peñas
Clinical and Translational Oncology, 2018, 20 : 97 - 107
[28] SEOM clinical guideline on unknown primary cancer (2017)
Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernandez, I.
Gimenez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Segui, M. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 89 - 96
[29] Clinical guideline SEOM: cancer of unknown primary site
R. Collado Martín
A. García Palomo
L. de la Cruz Merino
P. Borrega García
F. J. Barón Duarte
Clinical and Translational Oncology, 2014, 16 : 1091 - 1097
[30] SEOM clinical guideline for treatment of kidney cancer (2019)
M. Lázaro
B. P. Valderrama
C. Suárez
G. de-Velasco
C. Beato
I. Chirivella
A. González-del-Alba
N. Laínez
M. J. Méndez-Vidal
J. A. Arranz
Clinical and Translational Oncology, 2020, 22 : 256 - 269

← 1 2 3 4 5 →